PATH vs RKDA · P/E 19, rev $1.61B vs rev $5.0M
Uipath Inc (PATH) versus Arcadia Biosciences Inc (RKDA) — a side-by-side from cached financials, not a winner call.
Uipath Inc (PATH) is a software - infrastructure company listed on US.
Arcadia Biosciences Inc (RKDA) is a packaged foods company listed on NASDAQ.
Latest reported PATH revenue for 2026-01-31 was $1.61B. Net income was $282.3M. Revenue was up 12.7% from 2025-01-31 to 2026-01-31. PATH currently screens at market cap $6.07B and trailing P/E 19.4.
Latest reported RKDA revenue for 2024-12-31 was $5.0M. Net income was -$7.0M. Revenue was up 13.3% from 2023-12-31 to 2024-12-31. RKDA currently screens at market cap $1.7M.
PATH currently screens at market cap $6.07B and trailing P/E 19.4. RKDA currently screens at market cap $1.7M.
Not investment advice. Open the PATH and RKDA stock pages for the full models.
Not investment advice.